Search

Displaying results 2811 - 2820 of 10000 in total
  1. Indication

    Unresectable Stage III Non-small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0123170
    Drugs: Durvalumab
    Synonyms: Unresectable Stage III Non-small Cell Lung Cancer, Unresectable Stage III Non-small-cell Lung Cancer
  2. Indication

    Advanced RET-fusion Non Small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0144083
    Drugs: Pralsetinib
    Synonyms: Advanced RET-fusion Non Small Cell Lung Cancer
  3. Indication

    Stage 3 Non-Small Cell Lung Carcinoma (NSCLC)

    go.drugbank.com/conditions/DBCOND0144292
    Drugs: Pembrolizumab
    Synonyms: Stage 3 Non-Small Cell Lung Carcinoma (NSCLC)
  4. Drug

    Dyphylline

    go.drugbank.com/drugs/DB00651
    ApprovedWithdrawn

    Dyphylline is a theophylline derivative with broncho- and vasodilator properties. It is typically used in the management of asthma, cardiac dyspnea, and bronchitis.

    Mixtures: Dy G, Jay-Phyl
  5. Drug

    rdESAT-6

    go.drugbank.com/drugs/DB21906
    Approved

    rdESAT-6 is a recombinant dimer of Mycobacterium tuberculosis early secretory antigenic target used as an ingredient in the diagnostic agent SIILTIBCY along with rCFP-10.

  6. Drug

    Iobitridol

    go.drugbank.com/drugs/DB12407
    ApprovedWithdrawn

    Iobitridol has been used in trials studying the diagnostic of Diagnostic Imaging, Coronary Artery Disease, Type 2 Diabetes Mellitus, and Coronary Atherosclerosis.

    Categories: Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media, X-Ray Contrast Media, Iodinated
  7. Drug

    Amedalin

    go.drugbank.com/drugs/DB09188
    Experimental

    It has no significant effect on reuptake of serotonin and dopamine and no antihistamine or anticholinergic properties. This drug was never marketed.

  8. Drug

    Rheinanthrone

    go.drugbank.com/drugs/DB13175
    Experimental

    It is commonly produced by plants of the Rheum species [L772].

  9. Drug

    DDP-200

    go.drugbank.com/drugs/DB05919
    Experimental

    DDP200 is developed by Dynogen for the treatment of non-incontinent form of overactive bladder (OAB) with particular focus on both male and female patients with urinary frequency, urinary urgency and nocturia

  10. Drug

    Modafinil

    go.drugbank.com/drugs/DB00745
    ApprovedInvestigational

    Narcolepsy is caused by dysfunction of a family of wakefulness-promoting and sleep-suppressing peptides, the orexins, whose neurons are activated by modafinil. … The exact mechanism of action is unclear, although in vitro studies have shown it to inhibit the reuptake of dopamine by binding to the dopamine reuptake pump, and lead to an increase in extracellular